Scopolamine and Infectious peritonitis - a phase IV clinical study of FDA data


Infectious peritonitis is reported only by a few people who take Scopolamine.

The phase IV clinical study analyzes which people take Scopolamine and have Infectious peritonitis. It is created by eHealthMe based on reports of 3,722 people who have side effects while taking Scopolamine from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

3,722 people reported to have side effects when taking Scopolamine.
Among them, 4 people (0.11%) have Infectious peritonitis.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 3,733 Scopolamine users for its effectiveness, alternative drugs and more.

What is Infectious peritonitis?

Infectious peritonitis (inflammation of the peritoneum, typically caused by bacterial infection) is found to be associated with 547 drugs and 333 conditions by eHealthMe.

Number of Scopolamine and Infectious peritonitis reports submitted per year:

Could Scopolamine cause Infectious peritonitis?

Time on Scopolamine when people have Infectious peritonitis *:

  • < 1 month: 66.67 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 33.33 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Infectious peritonitis when taking Scopolamine *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Infectious peritonitis when taking Scopolamine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Scopolamine *:

  1. Aspirin: 3 people, 75.00%
  2. Lansoprazole: 2 people, 50.00%
  3. Methylprednisolone: 2 people, 50.00%
  4. Acyclovir: 2 people, 50.00%
  5. Allopurinol: 2 people, 50.00%
  6. Clorazepate Dipotassium: 2 people, 50.00%
  7. Haldol: 2 people, 50.00%
  8. Levofloxacin: 2 people, 50.00%
  9. Lorazepam: 2 people, 50.00%
  10. Ludiomil: 2 people, 50.00%

Common side effects people have besides Infectious peritonitis *:

  1. Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract): 2 people, 50.00%
  2. Cholangitis (infection of the bile duct): 2 people, 50.00%
  3. Confusion: 2 people, 50.00%
  4. Fall: 2 people, 50.00%
  5. Systemic Mycosis (fungal infections of the body): 1 person, 25.00%
  6. Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 1 person, 25.00%
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 25.00%
  8. Akathisia (a movement disorder characterized by a feeling of inner restlessness): 1 person, 25.00%
  9. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 1 person, 25.00%
  10. Cytomegalovirus Enterocolitis (virus infection of intestine and colon): 1 person, 25.00%

Common conditions people have *:

  1. Systemic Mycosis (fungal infections of the body): 1 person, 25.00%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 25.00%
  3. Multiple Myeloma (cancer of the plasma cells): 1 person, 25.00%
  4. Hiv Infection: 1 person, 25.00%
  5. Bone Marrow Conditioning Regimen: 1 person, 25.00%
  6. Anaesthesia: 1 person, 25.00%
  7. Abdominal Pain: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Scopolamine and have Infectious peritonitis?

Check whether Infectious peritonitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Infectious peritonitis and when was it recovered:

Expand to all the drugs that have ingredients of scopolamine:

Alternative drugs to, pros and cons of Scopolamine:

Common Scopolamine side effects:

Browse all side effects of Scopolamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infectious peritonitis treatments and more:

COVID vaccines that are related to Infectious peritonitis:

All the drugs that are associated with Infectious peritonitis:

All the conditions that are associated with Infectious peritonitis:

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine (the active ingredients of Scopolamine) and Scopolamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: